• Forum
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Morning ReviewDaily market recap and key overnight highlights
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • PortfolioInderes model portfolio
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Earnings SeasonCompare EPS estimates to reported results
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Q&A
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Medicortex International

2.30 SEK

+4.55 %

Less than 1K followers

MEDFIN B

NGM Growth Market

Medical Equipment & Services

Health Care

Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Compare
+4.55 %
-14.81 %
-23.33 %
-29.45 %
-29.45 %
-30.30 %
-96.02 %
-98.00 %
-98.58 %

Medicortex International is a medical technology company that develops diagnostic solutions for traumatic brain injuries, with a focus on biomarker-based tests. The company conducts research and development with the goal of enabling rapid and accessible diagnostics and works long-term with the development of treatment solutions. The business has an international focus.

Read more
Market cap
7.87M SEK
Turnover
14.15K SEK
Revenue
4.98M
EBIT %
-117.87 %
P/E
-
Dividend yield-%
-
Revenue and EBIT-%
EPS and dividend
Financial calendar
28/8
2026

Interim report Q2'26

All
Press releases
3rd party
ShowingAll content types

Revenue and EBIT-%

Revenue M

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Regulatory press release2026-06-30 18:10

Medicortex International: förvärvet slutfört, NGM-villkor uppfyllda, Adrian Harel ny VD

Medicortex International
Regulatory press release2026-06-30 14:04

Kommuniké från årsstämma i Medicortex International AB (publ) den 30 juni 2026

Medicortex International
Regulatory press release2026-06-30 11:38

NOSIUM byter namn till Medicortex International AB (publ) – registrerat hos Bolagsverket

Medicortex International

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Regulatory press release2026-06-18 12:05

NOSIUM AB (publ)har erhållit villkorat godkännande för fortsatt notering på NGM Growth Market

Medicortex International
Regulatory press release2026-06-05 16:30

RÄTTELSE: NOSIUM AB (publ) publicerar komplett årsredovisning för 2025 inklusive revisionsberättelse

Medicortex International
Regulatory press release2026-06-05 14:00

NOSIUM AB (publ) publicerar årsredovisning för 2025 och uppdaterar kring processen med Medicortex

Medicortex International
Regulatory press release2026-06-02 08:30

KALLELSE TILL ÅRSSTÄMMA I NOSIUM AB (PUBL)

Medicortex International
Regulatory press release2026-05-28 15:00

NOSIUM AB (publ) offentliggör delårsrapport för perioden januari–mars för 2026

Medicortex International
Regulatory press release2026-05-28 14:50

NOSIUM AB (publ) informerar om nedskrivning av Dr Sannas Sweden AB och uppdaterar tidplan för årsredovisning

Medicortex International
Regulatory press release2026-05-27 11:12

NOSIUM UPPMÄRKSAMMAR: BREV FRÅN MEDICORTEX STYRELSEORDFÖRANDE TILL AKTIEÄGARNA

Medicortex International
Regulatory press release2026-05-22 09:21

NOSIUM UPPMÄRKSAMMAR: MEDICORTEX FÅR FÖRLÄNGNING AV DoD-PROJEKT

Medicortex International
Regulatory press release2026-04-28 12:00

NOSIUM AB (publ) – Extra bolagsstämma den 28 april 2026

Medicortex International
Regulatory press release2026-04-27 10:49

NOSIUM AB (publ) ingår avtal om försäljning av Dr Sannas Sweden AB

Medicortex International
Regulatory press release2026-03-31 08:00

KALLELSE TILL EXTRA BOLAGSSTÄMMA I NOSIUM AB (PUBL)

Medicortex International
Regulatory press release2026-03-13 15:20

NOSIUM SÄKERSTÄLLER KAPITALBAS GENOM FINANSIERING OM 4 MSEK

Medicortex International
Regulatory press release2026-02-20 14:00

NOSIUM AB (publ) offentliggör bokslutskommuniké för 2025

Medicortex International
Regulatory press release2025-12-29 08:30

MEDICORTEX LÄMNAR IN ANSÖKAN TILL NGM & UPPNÅR 89,9 PROCENT AKTIEÄGARANSLUTNING

Medicortex International
Regulatory press release2025-12-12 12:55

MEDICORTEX BEVILJAS EUROPEISKT PATENT – STÄRKER SKYDDET FÖR UNIK TBI-DIAGNOSTIK

Medicortex International
Regulatory press release2025-12-08 12:06

AKTIEÄGARE REPRESENTERANDE ÖVER 80 PROCENT I MEDICORTEX ANSLUTER TILL FÖRVÄRVET

Medicortex International
Regulatory press release2025-11-27 09:50

NOSIUM AB (publ) offentliggör delårsrapport för perioden juli–september 2025

Medicortex International